MM-D37K

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameMM-D37K
Drug Alias NameMM-D37K
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionCyclin-dependent kinase 6 inhibitorsCyclin-dependent kinase 4 inhibitors
TargetsCyclin-dependent kinase 6Cyclin-dependent kinase 4
Therapy Area/IndicationsUrinary Bladder NeoplasmsGastrointestinal NeoplasmsMelanoma +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesMetamax
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMetamax
Active IndicationsN/A
Inactive IndicationsUrinary Bladder NeoplasmsGastrointestinal NeoplasmsMelanoma +[4] 

Other Information

ATC CodeN/A
Related LinksN/A